Search

everythinglearnresearchcommunity

for

Search:↓

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

CFx-δ2 from stem cells helps heal burn wounds faster.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Lack of Cisd2 disrupts calcium balance in cells, leading to poorly functioning neutrophils.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Surgical excision is the best treatment for SCC.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Camellia sinensis seed flavonoids can reduce skin inflammation and damage from UV rays.

S1PR1 helps control inflammation in blood vessel cells by affecting gene activity differently in various cell types and locations.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Upadacitinib improved multiple immune-related conditions in one patient.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

SVF is safe and effective, but research quality is low; new guidelines are proposed to improve future studies.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.